Showing results (11-20 of 5,175) with videos related to
Sort By:
Pageof 518
The Prostate|April 1, 1996
Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancerS R Denmeade, X S Lin, J T IsaacsThe Prostate|June 22, 2000
Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cellsB Tombal, A T Weeraratna, S R Denmeade, et al.The Prostate|December 5, 2006
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?Simon A Williams, Pratap Singh, John T Isaacs, et al.The Prostate|November 20, 1997
Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigarginX S Lin, S R Denmeade, L Cisek, et al.Oncotarget|January 31, 2013
Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancerW Nathaniel Brennen, Shuangling Chen, Samuel R Denmeade, et al.The Prostate|May 27, 1999
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cellsS R Denmeade, X S Lin, B Tombal, et al.Biochemistry|March 14, 2009
Prostate-specific antigen is a "chymotrypsin-like" serine protease with unique P1 substrate specificityAaron M LeBeau, Pratap Singh, John T Isaacs, et al.Cell Death and Differentiation|April 26, 2002
A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosisB Tombal, S R Denmeade, J-M Gillis, et al.Chemistry & Biology|July 19, 2008
Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigenAaron M LeBeau, Pratap Singh, John T Isaacs, et al.Asian Journal of Urology|February 19, 2019
Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancerEmmanuel S Akinboye, W Nathaniel Brennen, Samuel R Denmeade, et al.Pageof 518